Event Information

[Please note that this event has already taken place.]

Over the last decade, cell and gene therapies have made remarkable progress, and deal-making in this space is rising rapidly.

We hosted One Nucleus‘ panel event, to discuss the latest opportunities and challenges involved in M&A, VC and licensing transactions in this area. The session will cover topics such as “what makes these different to deals for small molecules or other types of therapies?” and “what are the top priorities for those looking to invest in, or acquire, cell or gene therapy businesses?” The expert panel shared their valuable insights on M&A trends, lessons learnt from licensing deals, the regulatory landscape that impacts these deals, and key ingredients needed to make them a success.

For more information on this event, click here (please note, before you start to register for this event you must sign in or create an account.)